Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

51.79USD
4:00pm EDT
Change (% chg)

$0.39 (+0.76%)
Prev Close
$51.40
Open
$51.42
Day's High
$51.97
Day's Low
$51.20
Volume
711,005
Avg. Vol
922,586
52-wk High
$52.33
52-wk Low
$39.90

BAX.N

Chart for BAX.N

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $27,856.61
Shares Outstanding(Mil.): 541.96
Dividend: 0.13
Yield (%): 1.01

Financials

  BAX.N Industry Sector
P/E (TTM): 5.71 34.29 30.07
EPS (TTM): 9.00 -- --
ROI: 35.47 12.63 13.05
ROE: 57.96 14.68 14.20

BRIEF-Baxter CEO José Almeida's FY 2016 compensation $5.8 mln vs $7.95 mln in FY 2015

* Ceo josé almeida's fy 2016 total compensation $5.8 million versus $7.95 million in fy 2015 - sec filing Source text for Eikon: Further company coverage:

Mar 17 2017

BRIEF-Ameren CEO Warner L. Baxter's 2016 compensation $6.6 mln vs $6.5 mln in 2015

* Ameren corp- ceo warner l. Baxter's total 2016 compensation was $6.6 million versus $6.5 million in 2015 Source text for Eikon: Further company coverage:

Mar 15 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK, March 13 Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

BRIEF-Skin Elements enters into agreement with Baxter Laboratories

* Entered into a Good Manufacturing Practice (GMP) agreement with Baxter Laboratories Pty Ltd

Mar 07 2017

BRIEF-Third Point sells 5.9 mln shares of Baxter International's common stock in block trade on Feb 28

* Third Point LLC says on Feb 28, it sold about 5.9 mln shares of Baxter International Inc's common stock in a block trade at $50.35 per share

Mar 01 2017

BRIEF-Baxter and Scinopharm announce partnership for generic oncology injectables

* Baxter and Scinopharm announce exclusive strategic partnership for generic oncology injectables

Feb 28 2017

BRIEF-Baxter debuts enteral nutrition ENFit syringe and accessory line in clinical nutrition week 2017

* Baxter debuts enteral nutrition ENFit syringe and accessory line during clinical nutrition week 2017

Feb 16 2017

BRIEF-Baxter appoints Stephen Oesterle to its board

* Appointment brings total number serving on board to 12 Source text for Eikon: Further company coverage:

Feb 08 2017

Siemens to pick banks for blockbuster Healthineers listing: sources

FRANKFURT German industrial group Siemens will shortly start picking banks to organize a stock market listing of its healthcare business, which could be valued at up to 37 billion euros ($40 billion) including debt, three people close to the matter said.

Jan 25 2017

More From Around the Web

Earnings vs. Estimates